Pancreatic Cancer Research

ResearcherSojo UniversityActive in the last 2 years

Keishi Yamasaki

Matched on ORCID iD 0000-0003-0537-2367; OpenAlex author ID A5005102682. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 8

  1. Caspase-Independent Cell Death Induced by a Nitric Oxide Donor Derived from Valproic Acid in Human Pancreatic Cancer Cells. Last author DOI 10.1248/bpb.b25-00770↗
  2. A Phenylbutyrate-Derived Nitric Oxide Donor Induces Pancreatic Cancer Cell Death Accompanied by Impairment of Autophagy-Related Pathways and HIF-1α Reduction. Co-author DOI 10.1248/bpb.b26-00297↗
  3. Novel Diclofenac-NO Donor With High Affinity for Human Serum Albumin Induces Endoplasmic Reticulum Stress-mediated Cell Death in Human Pancreatic Cancer Cells. Last author DOI 10.21873/anticanres.17204↗
  4. Ibuprofen‑derived nitric oxide donors with a high affinity to human serum albumin induce cell death in pancreatic cancer cells through a non‑caspase 3/7‑mediat… Last author DOI 10.3892/br.2024.1847↗
  5. The Nitrated Form of Nateglinide Induces Apoptosis in Human Pancreatic Cancer Cells Through a Caspase-dependent Mechanism. Last author DOI 10.21873/anticanres.15601↗
  6. Novel nitric oxide donor, nitrated phenylbutyrate, induces cell death of human pancreatic cancer cells and suppresses tumor growth of cancer xenografts. Last author DOI 10.3892/or.2022.8393↗
  7. Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acsomega.9b00537↗
  8. Glutamine Deprivation Enhances Acetyl-CoA Carboxylase Inhibitor-induced Death of Human Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.13036↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masaki Otagiri · 8 shared papers, 2018–2026 · strength 1.50
  2. Koji Nishi · 7 shared papers, 2018–2026 · strength 1.39
  3. Takuro Beppu · 5 shared papers, 2022–2026 · strength 1.09
  4. Kaho Takasaki · 4 shared papers, 2024–2026 · strength 1.01
  5. Kazuaki Taguchi · 1 shared paper, 2019 · strength 0.11
  6. Yuko Okamoto · 1 shared paper, 2019 · strength 0.11
  7. Nagahiko Yumita · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.